The results were encouraging - those on the 0.5 mg dose experienced an average weight loss of 7.6 kg (16.8 pounds) in three months and 11.5 kg (25.4 pounds) over six months
You can get enrolled in retatrutide trials by visiting clinicaltrials.gov
Weight reduction can enhance insulin sensitivity, lower fasting glucose, and support cardiometabolic health
Usually, youll experience about a 1 percent decrease in testosterone each year of your life once you hit the age of 30
On June 4, the FDA approved Novo Nordisk's semaglutide as a weight-loss drug under the trade name wegovy
J Clin Investig 131(12) Shirazi RH, Dickson SL, Skibicka KP (2013) Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward